Month: June 2025

LEADING EDGE MATERIALS ANNOUNCES UP TO C$4,000,000 NON-BROKERED PRIVATE PLACEMENT NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER, OR A SOLICITATION OF ANY OFFER, TO BUY OR SUBSCRIBE FOR ANY SECURITIES IN LEADING EDGE MATERIALS IN ANY JURISDICTION. Vancouver, June 10, 2025 – Leading Edge Materials Corp. (“Leading Edge Materials” or the “Company”) (TSXV: LEM) (Nasdaq First North: LEMSE) (OTCQB: LEMIF) announces the intent to complete a non-brokered private placement of up to 25,000,000 units (“Units”) at a price of C$0.16 per Unit for aggregate gross proceeds of up to C$4,000,000...

SYDNEY, June 11, 2025 (GLOBE NEWSWIRE) — IREN Limited (NASDAQ: IREN) (ACN 629 842 799) (“IREN”) today announced the pricing of its offering of $500 million aggregate principal amount of 3.50% convertible senior notes due 2029 (the “notes”) in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Key details of the transaction$500 million convertible senior notes offering (3.50% coupon, 30% conversion premium) Offering size was increased from the previously announced offering size of $450 million aggregate principal amount of notes Capped call transactions entered into in connection with the notes, which are expected generally to provide a hedge upon conversions up to an initial cap price of $20.98 per share,...

On 10 June, 2025 AB Artea bankas (the Bank) has completed its own share (ISIN code LT0000102253) buy-back programme on the regulated market, which was carried out from 5 May, 2025. During this period, the Bank acquired 2,540,000 treasury shares, i.e. 96 % of the maximum number of shares within the limit set at the time of the programme’s expiry, for a total amount of EUR 2,225,741.28, at an average price of EUR 0.876 per share. This buyback program, the purpose of which is to reduce the Bank’s capital, was approved by the Management Board of Artea Bank on April 30, 2025, implementing the decision of the Bank’s ordinary general meeting of shareholders of March 31, 2025. Share buy-back was implemented under authorisation from the European Central Bank (ECB) on 15 August, 2024 to buy back up to 13,745,114 of its own shares....

This announcement contains information on transactions of the acquisition of own shares of AB Artea bankas (the Bank) carried during the period specified below under the Bank’s own share buy-back programme announced on 30 April 2025.    The period during which the acquisition of the Bank’s own shares under the programme was carried out – 05.05.2025 – 10.06.2025.    Period covered by this periodic report – 09.06.2025 – 10.06.2025.    Other information: Transaction overview Date Total number of shares purchased on the day ( units) Weighted average price (EUR) Total value of transactions (EUR) 2025.06.09100,0000.85585,499.352025.06.1040,0000.85834,320.00Total acquired during the current week 140,0000.856119,819.35Total acquired during the programme period 2,540,0000.8762,225,741.28      The...

EINDHOVEN, the Netherlands, June 11, 2025 (GLOBE NEWSWIRE) — ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function and independence in people with spinal cord injury and other movement disabilities, today announces that it will host a webcast to discuss its Q1 2025 business update and year-to-date highlights. The webcast will be held on June 17, 2025, at 2:00PM CET / 08:00AM ET. It will be hosted by CEO Dave Marver. To join the session, please register using this link. About ONWARD Medical ONWARD Medical is the leading neurotechnology company pioneering therapies to restore movement, function and independence in people with spinal cord injury (SCI) and other movement disabilities. Building on more than a decade of scientific discovery, preclinical...

Ivry-sur-Seine, France, June 11, 2025 – 7:30AM Fnac Darty implements a share buyback program Fnac Darty has announced the implementation of a share buyback program for a total of 600,000 shares as part of the share buyback program authorised at the Shareholders’ Meeting of May 28, 2025. A first buyback mandate has been granted to investment services provider NATIXIS for a maximum amount of €5 million. This initiative follows on from the Board of Directors’ decision to allow share buyback in the proportion necessary to offset the dilution caused by the vesting of free shares allocated to the Group’s employees and Corporate Officers. CONTACTS ANALYSTS/INVESTORSDomitille Vielle — Head of Investor Relations — domitille.vielle@fnacdarty.com — +33 (0)6 03 86 05 02Laura Parisot — Investor Relations Manager — laura.parisot@fnacdarty.com — +33 (0)6 64 74 27 18 PRESSBénédicte...

Press release CROSSJECT advances on the development of ZEPIZURE® Junior, its solution for epilepsy crises in childrenAnnounces the effective calibration of ZENEO® for the use of ZEPIZURE® in the pediatric population. CROSSJECT completed an echography clinical study allowing to determine and validate the targeted depth of injection in children as compared to adults.Dijon, France 11 June 2025 (07h30 CET) — CROSSJECT (ISIN: FR0011716265; Euronext: ALCJ), the specialty pharma company in advanced phases of development and registration for ZEPIZURE® in adults, is progressing in the development of its pediatric version of ZEPIZURE®, branded ZEPIZURE® Junior. According to the 2022 National Survey of Children’s Health and as reported by the U.S. Centers for Disease Control and Prevention (CDC) on its “Epilepsy Facts & Stats” pages,...

Company Announcement 11 June 2025Announcement No. 18 NKT A/S concludes share buyback programme On 21 May 2025, NKT A/S initiated a share buyback programme to meet obligations relating to the Company’s share-based incentive programmes for employees and employee share programme, as informed in Company Announcement no. 17 of 21 May 2025. This share buyback programme has now been concluded. The share buyback programme was executed in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour rules. Between 22 May 2025 and 10 June 2025, NKT A/S has bought back 268,949 shares for a total amount of DKK 146.1m (EUR 19.6m).Trading days Number of shares bought back Average transaction price Amount in DKK22 May...

In May, EfTEN Real Estate Fund AS earned consolidated rental income of EUR 2,643 thousand, increasing by EUR 33 thousand compared to April. The increase in rental income is  mainly related to the higher revenue in the logistics segment (including the first full month of rental income from the Paemurru logistics centre) and contract-based rent increases in the elderly care segment. The Fund’s consolidated EBITDA in May totalled EUR 2,229 thousand (April: EUR 2,183 thousand). Adjusted cash flow (EBITDA less loan principal repayments and interest expenses) amounted to EUR 1,148 thousand, an increase of EUR 138 thousand compared to April. The portfolio vacancy rate decreased to 4.0% (down 0.7 percentage points), mainly due to new lease agreements signed in the office building at Pärnu mnt 102 in Tallinn. During the first five months of 2025,...